| (GBp) | Mar 2025 | Y/Y change |
|---|---|---|
| Revenue | 1.97M | 72.98% |
| Operating expense | — | — |
| Net income | -1.71M | -23.05% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, FAB.L returned -15.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -19.6% |
| 1 year | -15.1% |
| 5 years | -90.8% |
| All-time high | GBX 213.00 (Dec 2017) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what £1,000 in FAB.L would be worth today ›No. Fusion Antibodies plc has not paid a dividend in the past 12 months.
Fusion Antibodies plc is part of the Healthcare sector.
Fusion Antibodies plc has a market cap of 14.08M GBp, based on the latest quote.
